Published: 7 September 2017

Publications

Quarterly Summary of Medsafe’s Early Warning System Communications

This article is more than five years old. Some content may no longer be current.

Prescriber Update 38(3): 39
September 2017

The early warning system provides current and historical information on safety concerns for medicines and medical devices. These warnings are intended to help consumers and healthcare professionals make informed decisions about their use of medicines and medical devices.

More information about the early warning system can be found on the Medsafe website (www.medsafe.govt.nz/Projects/B2/EWS.asp).

Consumer Information Leaflets provide information about medicines and medical devices or medical conditions to consumers.

Date Communication Topic
2 August 2017 Consultation Changes to the Label Statements Database for sedating antihistamines available without prescription (Closes 29 Sep 2017)
20 July 2017 Consultation Proposed change to warning statements on labels of oral non-steroidal anti-inflammatory drugs (NSAIDs) available without a prescription (Closes 15 Sep 2017)
11 July 2017 Alert Communication UPDATE — Heater-cooler devices used during cardiac surgery: risk of infection with Nontuberculous Mycobacterium species - advice and recommendations
11 July 2017 Alert Communication Consumer Level Recall — NovoPen® Echo®
7 July 2017 Alert Communication Use of Tramadol During Breastfeeding
12 May 2017 Monitoring Communication Direct-acting antiviral (DAA) regimens and liver failure
27 March 2017 Dear Healthcare Professional Letter Zelboraf — Risk of Dupuytren's Contracture and Plantar Fascial Fibromatosis

If you would like to receive Medsafe’s early warning communications you can subscribe at www.medsafe.govt.nz/profs/subscribe.asp.

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /